| | Title | Authors / Editors | Date |
|
unige:24426 |
Increase of [(18)F]FLT tumor uptake in vivo mediated by FdUrd: toward improving cell proliferation positron emission tomography |
Viertl, David; Bischof Delaloye, Angelika; Lanz, Bernard; Poitry-Yamate, Carole; ... Buchegger, Franz |
2011 |
|
unige:23494 |
[¹¹C]acetate PET/CT visualizes skeletal muscle exercise participation, impaired function, and recovery after hip arthroplasty; first results |
Buchegger, Franz; Ratib, Osman; Willi, Jean-Pierre; Steiner, Charles Alexis; ... Jung, Maximilien |
2011 |
|
unige:23497 |
⁹⁰Y Time-of-flight PET/MR on a hybrid scanner following liver radioembolisation (SIRT) |
Wissmeyer, Michael; Heinzer, Susanne; Majno, Pietro; Buchegger, Franz; ... Terraz, Sylvain |
2011 |
|
unige:14889 |
Magnetic and in vitro heating properties of implants formed in situ from injectable formulations and containing superparamagnetic iron oxide nanoparticles (SPIONs) embedded in silica microparticles for magnetically induced local hyperthermia |
Le Renard, Pol-Edern; Lortz, Rolf; Senatore, Carmine; Rapin, Jean-Philippe; ... Jordan, Olivier |
2011 |
|
unige:20970 |
Possible misinterpretation of the mode of action of therapeutic antibodies in vitro: homotypic adhesion and flow cytometry result in artefactual direct cell death |
Golay, Josee; Bologna, Luca; Andre, Pierre-Alain; Buchegger, Franz; ... Introna, Martino |
2010 |
|
unige:21326 |
Charge dependent substrate activity of C3' and N3 functionalized, organometallic technetium and rhenium-labeled thymidine derivatives toward human thymidine kinase 1 |
Struthers, Harriet; Viertl, David; Kosinski, Marek; Spingler, Bernhard; ... Schibli, Roger |
2010 |
|
unige:20850 |
Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice |
Cirstoiu, Adriana; Buchegger, Franz; Lange, Norbert; Bossy, Leila; ... Delie Salmon, Florence |
2010 |
|
unige:20667 |
Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants |
Wilbur, D Scott; Park, Steven I.; Chyan, Ming-Kuan; Wan, Feng; ... Press, Oliver W. |
2010 |
|
unige:2163 |
PET/CT trois phases à la 18F-fluorocholine dans l'évaluation de la récidive du cancer de la prostate |
Steiner, Charles |
2009 |
|
unige:19938 |
High efficiency production and purification of 86Y based on electrochemical separation |
Lukic, Dragoljub; Tamburella, Claire; Buchegger, Franz; Beyer, Gerd-Jurgen; ... Seimbille, Yann |
2009 |
|
unige:19744 |
Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells |
Cirstoiu, Adriana; Buchegger, Franz; Bossy, Leila; Kosinski, M; ... Delie Salmon, Florence |
2009 |
|
unige:19568 |
Fluorodeoxyuridine mediated cell cycle synchronization in S-phase increases the Auger radiation cell killing with 125I-iododeoxyuridine |
Perillo-Adamer, F.; Kosinski, M.; Dupertuis, Yves Marc; Viertl, D.; ... Buchegger, Franz |
2009 |
|
unige:19583 |
Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence |
Steiner, Ch; Vees, Hansjoerg; Zaidi, Habib; Wissmeyer, Michael; ... Buchegger, Franz |
2009 |
|
unige:20170 |
Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study |
Weber, Damien; Casanova, Nathalie; Zilli, Thomas; Buchegger, Franz; ... Miralbell, Raymond |
2009 |
|
unige:1863 |
[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma |
Weber, Damien; Zilli, Thomas; Buchegger, Franz; Casanova, Nathalie; ... Miralbell, Raymond |
2008 |
|
unige:1864 |
Radiolabeled and native antibodies and the prospect of cure of follicular lymphoma |
Buchegger, Franz; Press, Oliver W.; Bischof Delaloye, Angelika; Ketterer, Nicolas |
2008 |
Ciblage tumoral par anticorps, peptides et nucléotides radiomarqués (221)
add all
remove all
